StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.85+0.02 (+2.40%)

Close on Nov 13, 2026Market cap $98.06MP/E –Yield –

NovaBridge Biosciences statistics

27 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Dec 31, 2025
Share price as of
–

Valuation ratiosIndustry

Market Cap
CN¥654.67M
–
Enterprise Value
CN¥654.67M
–

Share statisticsIndustry

Shares Change (YoY)
18.0%
3.69%
Float
177M
325M
Shares Held by Insiders
33.3%
19.6%
Shares Held by Institutions
9.30%
–

Short sellingIndustry

Short Interest
4M
–
Short Interest Change
-3.29%
–
Days to Cover
6.89
–

Stock price statisticsIndustry

Price Change (1 Week)
-6.55%
–
Price Change (1 Month)
-34.1%
–
Price Change (3 Months)
-56.0%
–
Price Change (6 Months)
-53.3%
–
Price Change (YTD)
-78.6%
–
Price Change (1 Year)
-79.9%
–
Price Change (3 Years)
-50.0%
–
Price Change (5 Years)
-98.6%
–
Average Volume (10 Days)
558,757
–
Average Volume (20 Days)
549,553
–
Average Volume (90 Days)
421,784
–
Relative Volume
1.86
–
Relative Strength Index (14)
22.7
–
Volatility (1 Year)
65.7%
–
Beta (5 Years)
1.48
–

EfficiencyIndustry

Employee Count
220
767
WACC
12.5%
–

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodNBPS&P 500DifferenceNBP per yearS&P 500 per year
1 month-34.1%-3.0%−31.1 pts
3 months-55.3%-2.8%−52.5 pts
Year to date-78.6%+11.5%−90.1 pts
1 year-79.6%+13.5%−93.1 pts
3 years-48.2%+77.7%−125.9 pts-19.7%+21.1%
5 years-98.6%+72.6%−171.2 pts-57.3%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

4M NBP shares were sold short on Oct 30, 2026, down 3.3% from the previous report. At recent volumes it would take 6.9 days to buy them back. Over the last 20 sessions, 46.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20263,579,179-3.3%519,4916.9
Oct 15, 20263,700,826+12.7%349,87210.6
Sep 30, 20263,282,485-12.4%931,8953.5
Sep 15, 20263,746,443+4.5%219,19817.1
Aug 31, 20263,584,013-21.7%293,28012.2
Aug 14, 20264,575,902+1.2%225,16220.3
Jul 31, 20264,519,614+4.4%259,47517.4
Jul 15, 20264,327,479+24.7%712,1326.1
Jun 30, 20263,469,413-16.6%846,8874.1
Jun 15, 20264,161,491+16.1%491,2718.5
May 29, 20263,584,689-27.5%800,7194.5
May 15, 20264,942,765+19.6%1,079,1394.6

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?